SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BDR who wrote (1326)12/25/1997 11:55:00 PM
From: Dauntless  Read Replies (1) of 7041
 
Dale & thread

We should thank Mr. Wexler for pointing out in his post #1328 that......

>> "....the endpoints for the test were not the same as those used for the clinical trials of other male impotence drugs. The endpoint for the Phase III trial was not penetration."

He is correct, for once, the successful endpoint for the Zonagen clinical trial WAS different from that used for the trials of other drugs.

Zonagen's successful endpoint, as identified in the slide show (slide #6) that Mr. Wexler referenced:

Response:
increase in # successful intercourses (not just penetration)

Successful intercourse:
satisfaction of erection & penetration culminating in orgasm during vaginal intromission

IMHO, it seems that the Zonagen endpoint would be more difficult for these patients - and therefore the Zonagen results are even more impressive.

Others - success = penetration only
Vasomax - Success = satisfactory erection, penetration AND orgasm

Seems pretty convincing to me!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext